Best Researcher Award
Álvaro Carbayo
Hospital de la Santa Creu i Sant Pau, Spain
| Álvaro Carbayo | |
|---|---|
| Affiliation | Hospital de la Santa Creu i Sant Pau |
| Country | Spain |
| Scopus ID | 57219260055 |
| Documents | 29 |
| Citations | 497 |
| h-index | 11 |
| Subject Area | Neuroscience |
| Event | International Forensic Scientist Awards |
| ORCID | 0000-0001-9282-8603 |
Álvaro Carbayo is a neuroscience researcher affiliated with Hospital de la Santa Creu i Sant Pau in Spain. His documented research output includes work spanning neuromuscular disorders, neurodegenerative disease, genetic characterization, respiratory manifestations, and digital assessment of gait. Scopus records 29 documents, 497 citations, and an h-index of 11 for the identified author profile.[1]
Contents
Abstract
Álvaro Carbayo’s research profile is situated within neuroscience, with recent publications addressing amyotrophic lateral sclerosis (ALS), frontotemporal lobar degeneration (FTLD), peripheral neuropathies, inherited muscle disease, and clinically relevant genetic variants. His recent work demonstrates an emphasis on integrating clinical observation with molecular and digital assessment approaches. These studies include cohort-based methodological analysis, biomechanical gait evaluation, and investigation of disease-associated genetic variants.[2][3]
Keywords
Neuroscience; ALS; frontotemporal lobar degeneration; peripheral neuropathy; gait biomechanics; neuromuscular disorders; genetic variants; translational research.
Introduction
Contemporary neuroscience increasingly combines neurological examination, quantitative measurement, molecular genetics, and longitudinal clinical information. Carbayo’s recent publications reflect this multidisciplinary context, particularly in studies of rare neuromuscular and neurodegenerative conditions. The reported research addresses both characterization of disease mechanisms and improvement of clinical assessment methods.[3][4]
Research Profile
The profile combines clinical neuroscience with genomic and digital methodologies. Recent research includes analysis of ALS and FTLD through the SPIN cohort, digital biomechanical assessment of gait in peripheral neuropathies, and genetic investigations involving DES, CHMP2B, and ATP2A2 variants. These topics collectively concern diagnosis, phenotypic characterization, functional measurement, and understanding of inherited neurological and muscular disease.[2][4][5]
Research Contributions
- Clinical and methodological analysis of ALS and FTLD through cohort-based research.[2]
- Digital biomechanical evaluation of gait for patients affected by peripheral neuropathies.[3]
- Genetic characterization of uncommon variants associated with neuromuscular and neurodegenerative phenotypes.[4][5]
Publications
Recent publications include Methodological insights and clinical outcomes in ALS and FTLD: lessons from the SPIN cohort in Alzheimer’s & Dementia, published in August 2026; Digital biomechanical assessment of gait in patients with peripheral neuropathies in Journal of Neuroengineering and Rehabilitation; and studies of DES, CHMP2B, and ATP2A2 variants in neurological and neuropathological journals.[2][3][4][5][6]
Research Impact
The Scopus profile associated with Álvaro Carbayo reports 29 documents, 497 citations, and an h-index of 11.[1] These indicators provide quantitative information about indexed scholarly output and citation activity, while the publication record provides additional context concerning the clinical and methodological areas represented in the research.
Award Suitability
For consideration under the Best Researcher Award category of the International Forensic Scientist Awards, the documented profile provides evidence of sustained scholarly activity in neuroscience and recent contributions to clinically relevant neurological research. The combination of indexed publications, citation indicators, and studies addressing diagnostic, genetic, and functional dimensions of disease provides substantive material for an academic recognition assessment.
Conclusion
Álvaro Carbayo’s research record reflects a neuroscience-oriented program encompassing neurodegenerative disease, neuromuscular disorders, genetics, and quantitative clinical assessment. His recent publications and indexed bibliometric record provide a documented basis for evaluating his scholarly activity and research contributions within the stated award context.
External Links
References
- Elsevier. (n.d.). Scopus author details: Álvaro Carbayo, Author ID 57219260055. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=57219260055 - Methodological insights and clinical outcomes in ALS and FTLD: lessons from the SPIN cohort. (2026). Alzheimer’s & Dementia.
https://doi.org/10.1002/alz.71777 - Digital biomechanical assessment of gait in patients with peripheral neuropathies. (2025). Journal of Neuroengineering and Rehabilitation.
https://doi.org/10.1186/s12984-025-01694-w - Novel DES mutation presenting with isolated restrictive respiratory failure. Expanding the clinical spectrum. (2025). Neurologia.
https://doi.org/10.1016/j.nrleng.2025.04.008 - A Novel CHMP2B Splicing Variant in Atypical Presentation of Familial Frontotemporal Lobar Degeneration. (2025). Annals of Clinical and Translational Neurology.
https://doi.org/10.1002/acn3.70023 - A Homozygous ATP2A2 Variant Alters Sarcoendoplasmic Reticulum Ca2+-ATPase 2 Function in Skeletal Muscle and Causes a Novel Vacuolar Myopathy. (2025). Neuropathology and Applied Neurobiology.
https://doi.org/10.1111/nan.70000
